| 摘要 |
<p>The invention provides a pharmaceutical composition, pharmaceutical product or kit comprising a first active ingredient which is a beta2 (β2) adrenoreceptor agonist and a second active ingredient which is a leukotriene receptor antagonist, for use in the treatment of inflammatory disorders.</p> |
